What AI says about CURATE.AI
Data as of Oct 20, 2026Based on 531 AI responses
Reviewed by Dimitry Apollonsky
Mentioned in
5%
across CURATE.AI’s markets · since Jul 5
CURATE.AI in AI’s own words
Question: What platforms support n-of-1 therapy design or personalized medicine workflows?
Google AI ModeSep 29, 2026
CURATE.AI : An artificial intelligence platform geared toward dynamic dose and intervention optimization.
Question: What platforms support n-of-1 therapy design or personalized medicine workflows?
Google AI ModeSep 21, 2026
CURATE.AI : A proprietary AI/machine learning platform that treats each patient as a discrete case
Where AI mentions CURATE.AI
Position in answers
- Named first8%
- 2nd or 3rd21%
- Later71%
Each engine’s share of its own answers across CURATE.AI’s markets · since Jul 5
- ChatGPT Search4%
- Google AI Mode5%
A cited page to review
This page is cited in 38% of the answers that name CURATE.AI.
Check whether this page mentions your business and whether its details are accurate before contacting the publisher.
All-time evidence through 2026-09-29.
Review the page on pmc.ncbi.nlm.nih.gov (opens in a new tab)
Questions and answers
- Mentioned in
Excerpts where CURATE.AI appeared in the AI's answer
Google AI ModeSep 29, 2026, Google AI Mode CURATE.AI : An artificial intelligence platform geared toward dynamic dose and intervention optimization.
Google AI ModeSep 21, 2026, Google AI Mode CURATE.AI : A proprietary AI/machine learning platform that treats each patient as a discrete case
Sources AI cites
curate.ai 3%Other sites 97%
- 49%
- N-of-1 medicine - PMC · 26% (opens in a new tab)
- CURATE.AI COR-Tx platform as a digital therapy and ... · 6% (opens in a new tab)
- Physicians’ Perspectives on AI in Clinical Decision Support Systems: Interview Study of the CURATE.AI Personalized Dose Optimization Platform · 3% (opens in a new tab)
- CURATE.AI-assisted dose titration for anti-hypertensive personalized therapy: study protocol for a multi-arm, randomized, pilot feasibility trial using CURATE.AI (CURATE.AI ADAPT trial) · 3% (opens in a new tab)
- Artificial Intelligence (AI) Applications in Drug Discovery and Drug Delivery: Revolutionizing Personalized Medicine - PMC · 3% (opens in a new tab)
- Personalized dose selection platform for patients with solid tumors in ... · 3% (opens in a new tab)
- N-of-1 Healthcare: Challenges and Prospects for the Future of ... - PMC · 3% (opens in a new tab)
- Personalised Dosing Using the CURATE.AI Algorithm - PMC · 3% (opens in a new tab)
- 20%
- CURATE.AI: Optimizing Personalized Medicine with Artificial ... · 14% (opens in a new tab)
- Artificial Intelligence-Driven Designer Drug Combinations: From Drug Development to Personalized Medicine · 3% (opens in a new tab)
- Personalized medicine, digital innovation, and artificial intelligence: an analysis according to the different stakeholders · 3% (opens in a new tab)
